Lacosamide-13C, D3 solution

Descrição detalhada : Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat(R). This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.
Fórmula molecula r: 13CC12D3H15N2O3
Armazenamento : -20C
Embalagem : 1X1ML